Risk Factors for Progression of CKD with and without Diabetes

被引:22
作者
Zhang, Xiaohong [1 ,2 ]
Fang, Yuan [1 ,2 ]
Zou, Zhenhuan [1 ,2 ]
Hong, Pianpian [1 ,2 ]
Zhuo, Yongjie [1 ,2 ]
Xu, Yanfang [1 ,2 ]
Wan, Jianxin [1 ,2 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Blood Purificat Res Ctr, Dept Nephrol, Fuzhou 350005, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fujian Clin Res Ctr Metab Chron Kidney Dis, Fuzhou 350005, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; MANAGEMENT; OUTCOMES; HYPOALBUMINEMIA; CHOLESTEROL; MORTALITY; ALBUMIN;
D O I
10.1155/2022/9613062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We aim to identify independent risk factors to predict CKD progression to end stage renal disease (ESRD) in patients with or without diabetes. Methods. In this retrospective study, we enrolled CKD stage 3-4 patients between January 2013 and December 2018 and followed them until December 2020 or the initiation of dialysis. We used Kaplan-Meier to plot the survival curve. Univariate and multivariable Cox proportional hazards model was used to explore risk factors affecting the progression of CKD. The final model was used to construct nomogram for predicting CKD progression. Calibration plots and concordance index (C-index) were used to evaluate the accuracy and discrimination of the risk model. Results. We enrolled 309 CKD patients, including 80 cases in G3a, 98 cases in G3b, and 131 cases in G4. Among them, 141 patients had diabetes and 168 did not. The mean age of patients at enrolled was 57.86 & PLUSMN; 15.10 years, and 67% were male. The median follow-up time was 25.6 months. There were 81 patients (26.2%) that started dialysis in the total CKD cohort, 52 cases (36.9%) in the CKD with diabetes group, and 29 cases (17.3%) in the CKD without diabetes group. Hypoalbuminemia (HR =2.655, P < 0.001), proteinuria (HR =2.592, P=0.042), increased LDL (HR =2.494, P < 0.001), diabetes (HR =2.759, P < 0.001), hypertension (HR =3.471, P=0.037), and CKD stage (HR =2.001, P=0.046) were risk factors for CKD progression to ESRD in the overall population. For those without diabetes, only hypoalbuminemia (HR =2.938, P=0.030) was a risk factor for CKD progression to ESRD. For those with diabetes, both hypoalbuminemia (HR =2.758, P=0.002), the increased level of LDL (HR =3.982, P < 0.001), and CKD stage (HR =3.781, P=0.001) were risk factors for CKD progression to ESRD. The C-index of the final nomograms was 0.760 (P < 0.001). Conclusions. The results from our risk factor model suggest that CKD disease progression can be predicted and early strategic intervention is necessary for CKD patients to avoid renal function deterioration.
引用
收藏
页数:12
相关论文
共 52 条
[1]   Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Bikbov, Boris ;
Purcell, Carrie ;
Levey, Andrew S. ;
Smith, Mari ;
Abdoli, Amir ;
Abebe, Molla ;
Adebayo, Oladimeji M. ;
Afarideh, Mohsen ;
Agarwal, Sanjay Kumar ;
Agudelo-Botero, Marcela ;
Ahmadian, Elham ;
Al-Aly, Ziyad ;
Alipour, Vahid ;
Almasi-Hashiani, Amir ;
Al-Raddadi, Rajaa M. ;
Alvis-Guzman, Nelson ;
Amini, Saeed ;
Andrei, Tudorel ;
Andrei, Catalina Liliana ;
Andualem, Zewudu ;
Anjomshoa, Mina ;
Arabloo, Jalal ;
Ashagre, Alebachew Fasil ;
Asmelash, Daniel ;
Ataro, Zerihun ;
Atout, Maha Moh'd Wahbi ;
Ayanore, Martin Amogre ;
Badawi, Alaa ;
Bakhtiari, Ahad ;
Ballew, Shoshana H. ;
Balouchi, Abbas ;
Banach, Maciej ;
Barquera, Simon ;
Basu, Sanjay ;
Bayih, Mulat Tirfie ;
Bedi, Neeraj ;
Bello, Aminu K. ;
Bensenor, Isabela M. ;
Bijani, Ali ;
Boloor, Archith ;
Borzi, Antonio M. ;
Camera, Luis Alberto ;
Carrero, Juan J. ;
Carvalho, Felix ;
Castro, Franz ;
Catala-Lopez, Ferran ;
Chang, Alex R. ;
Chin, Ken Lee ;
Chung, Sheng-Chia ;
Cirillo, Massimo .
LANCET, 2020, 395 (10225) :709-733
[2]   Disorders of Lipid Metabolism in Chronic Kidney Disease [J].
Bulbul, Mustafa C. ;
Dagel, Tuncay ;
Afsar, Baris ;
Ulusu, Nuray N. ;
Kuwabara, Masanarini ;
Covic, Adrian ;
Kanbay, Mehmet .
BLOOD PURIFICATION, 2018, 46 (02) :144-152
[3]   Metformin for Type 2 Diabetes [J].
Caturano, Alfredo ;
Galiero, Raffaele ;
Pafundi, Pia Clara .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13) :1312-1312
[4]   A predictive model for progression of CKD [J].
Chang, Hsueh-Lu ;
Wu, Chia-Chao ;
Lee, Shu-Pei ;
Chen, Ying-Kai ;
Su, Wen ;
Su, Sui-Lung .
MEDICINE, 2019, 98 (26)
[5]   Chronic Kidney Disease Diagnosis and Management: A Review [J].
Chen, Teresa K. ;
Knicely, Daphne H. ;
Grams, Morgan E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13) :1294-1304
[6]   Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort [J].
Chiang, Heng-Pin ;
Lee, Jia-Jung ;
Chiu, Yi-Wen ;
Tsai, Jer-Chia ;
Hung, Chi-Chih ;
Hwang, Shang-Jyh ;
Chen, Hung-Chun .
AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (11) :1396-1407
[7]   Are filtered plasma proteins processed in the same way by the kidney? [J].
Comper, W. D. ;
Russo, L. M. ;
Vuchkova, J. .
JOURNAL OF THEORETICAL BIOLOGY, 2016, 410 :18-24
[8]   Serum albumin: Relationship to inflammation and nutrition [J].
Don, BR ;
Kaysen, G .
SEMINARS IN DIALYSIS, 2004, 17 (06) :432-437
[9]   Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference [J].
Eckardt, Kai-Uwe ;
Bansal, Nisha ;
Coresh, Josef ;
Evans, Marie ;
Grams, Morgan E. ;
Herzog, Charles A. ;
James, Matthew T. ;
Heerspink, Hiddo J. L. ;
Pollock, Carol A. ;
Stevens, Paul E. ;
Tamura, Manjula Kurella ;
Tonelli, Marcello A. ;
Wheeler, David C. ;
Winkelmayer, Wolfgang C. ;
Cheung, Michael ;
Hemmelgarn, Brenda R. .
KIDNEY INTERNATIONAL, 2018, 93 (06) :1281-1292
[10]   Risk Factors for Prognosis in Patients With Severely Decreased GFR [J].
Evans, Marie ;
Grams, Morgan E. ;
Sang, Yingying ;
Astor, Brad C. ;
Blankestijn, Peter J. ;
Brunskill, Nigel J. ;
Collins, John F. ;
Kalra, Philip A. ;
Kovesdy, Csaba P. ;
Levin, Adeera ;
Mark, Patrick B. ;
Moranne, Olivier ;
Rao, Panduranga ;
Rios, Pablo G. ;
Schneider, Markus P. ;
Shalev, Varda ;
Zhang, Haitao ;
Chang, Alex R. ;
Gansevoort, Ron T. ;
Matsushita, Kunihiro ;
Zhang, Luxia ;
Eckardt, Kai-Uwe ;
Hemmelgarn, Brenda ;
Wheeler, David C. .
KIDNEY INTERNATIONAL REPORTS, 2018, 3 (03) :625-637